Elke Bucha

605 total citations
27 papers, 466 citations indexed

About

Elke Bucha is a scholar working on Surgery, Hematology and Genetics. According to data from OpenAlex, Elke Bucha has authored 27 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 10 papers in Hematology and 9 papers in Genetics. Recurrent topics in Elke Bucha's work include Heparin-Induced Thrombocytopenia and Thrombosis (16 papers), Venomous Animal Envenomation and Studies (9 papers) and Venous Thromboembolism Diagnosis and Management (8 papers). Elke Bucha is often cited by papers focused on Heparin-Induced Thrombocytopenia and Thrombosis (16 papers), Venomous Animal Envenomation and Studies (9 papers) and Venous Thromboembolism Diagnosis and Management (8 papers). Elke Bucha collaborates with scholars based in Germany, Czechia and Sweden. Elke Bucha's co-authors include G Nowak, F Markwárdt, Götz Nowak, Günter Stein, G. Klebe, Andrea Olschewski, Johanna Deinum, Torsten Steinmetzer, Bernhard Baum and Ann Lövgren and has published in prestigious journals such as Kidney International, Journal of Pharmaceutical Sciences and Nephrology Dialysis Transplantation.

In The Last Decade

Elke Bucha

27 papers receiving 445 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elke Bucha Germany 12 312 232 187 122 87 27 466
J. Bichler Germany 13 137 0.4× 103 0.4× 107 0.6× 237 1.9× 32 0.4× 16 405
A Giles Canada 5 122 0.4× 125 0.5× 118 0.6× 116 1.0× 19 0.2× 9 317
Jawed Fareed United States 10 154 0.5× 219 0.9× 209 1.1× 76 0.6× 11 0.1× 16 402
Christian Pötschke Germany 10 147 0.5× 67 0.3× 16 0.1× 113 0.9× 63 0.7× 13 400
Rachel Petermann France 8 60 0.2× 17 0.1× 25 0.1× 126 1.0× 9 0.1× 25 258
Marie-Françoise Bloch France 10 124 0.4× 78 0.3× 76 0.4× 49 0.4× 2 0.0× 13 412
Jana Žolková Slovakia 10 32 0.1× 36 0.2× 43 0.2× 112 0.9× 13 0.1× 26 268
Helen R. McPherson United Kingdom 10 58 0.2× 41 0.2× 38 0.2× 125 1.0× 3 0.0× 14 317
Wouter A. van der Heijden Netherlands 10 13 0.0× 15 0.1× 30 0.2× 69 0.6× 55 0.6× 15 314
Esther Pellham United States 12 37 0.1× 12 0.1× 11 0.1× 218 1.8× 29 0.3× 24 433

Countries citing papers authored by Elke Bucha

Since Specialization
Citations

This map shows the geographic impact of Elke Bucha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elke Bucha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elke Bucha more than expected).

Fields of papers citing papers by Elke Bucha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elke Bucha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elke Bucha. The network helps show where Elke Bucha may publish in the future.

Co-authorship network of co-authors of Elke Bucha

This figure shows the co-authorship network connecting the top 25 collaborators of Elke Bucha. A scholar is included among the top collaborators of Elke Bucha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elke Bucha. Elke Bucha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bucha, Elke, et al.. (2012). Expression and Characterization of Recombinant Ecarin. The Protein Journal. 31(5). 353–358. 12 indexed citations
2.
Steinmetzer, Torsten, Bernhard Baum, J. Biela, et al.. (2012). Beyond Heparinization: Design of Highly Potent Thrombin Inhibitors Suitable for Surface Coupling. ChemMedChem. 7(11). 1965–1973. 9 indexed citations
3.
Nowak, Götz, et al.. (2007). Measurement of Maximum Thrombin Generation Capacity in Blood and Plasma Using the Thrombin Generation Assay (THROGA). Seminars in Thrombosis and Hemostasis. 33(5). 508–514. 3 indexed citations
5.
Nowak, Götz, et al.. (2005). Platelet Adhesion Assay-A New Quantitative Whole Blood Test to Measure Platelet Function. Seminars in Thrombosis and Hemostasis. 31(4). 470–475. 4 indexed citations
6.
Bucha, Elke, et al.. (2005). Is Platelet Adhesion Assay Able To Quantify Drug-Induced Platelet Dysfunction?. Seminars in Thrombosis and Hemostasis. 31(4). 476–481. 2 indexed citations
7.
Bucha, Elke, et al.. (2004). Anticoagulant efficacy of PEG-Hirudin in patients on maintenance hemodialysis. Kidney International. 65(2). 666–674. 11 indexed citations
8.
Nowak, G, et al.. (2003). Ecarin Chromogenic Assay – A New Method for Quantitative Determination of Direct Thrombin Inhibitors Like Hirudin. Pathophysiology of Haemostasis and Thrombosis. 33(4). 184–191. 62 indexed citations
9.
Bucha, Elke, et al.. (2000). Pharmacodynamics and pharmacokinetics of polyethylene glycol-hirudin in patients with chronic renal failure. Kidney International. 58(6). 2478–2484. 17 indexed citations
10.
Bucha, Elke, et al.. (1999). In vitro study of r-hirudin permeability through membranes of different haemodialysers. Nephrology Dialysis Transplantation. 14(12). 2922–2926. 24 indexed citations
11.
Meiring, Muriel, M. G. Lötter, P N Badenhorst, et al.. (1999). Sites of elimination and pharmacokinetics of recombinant [131I]lepirudin in baboons. Journal of Pharmaceutical Sciences. 88(5). 523–529. 6 indexed citations
12.
Nowak, G, et al.. (1997). Anticoagulation with r-hirudin in regular haemodialysis with heparin-induced thrombocytopenia (HIT II). The first long-term application of r-hirudin in a haemodialysis patient.. PubMed. 109(10). 354–8. 48 indexed citations
13.
Bucha, Elke, et al.. (1996). Quantitative Determination of Hirudin in Blood and Body Fluids. Seminars in Thrombosis and Hemostasis. 22(2). 197–202. 99 indexed citations
14.
Nowak, Götz & Elke Bucha. (1995). Prothrombin conversion intermediate effectively neutralizes toxic levels of hirudin. Thrombosis Research. 80(4). 317–325. 14 indexed citations
15.
Nowak, G, et al.. (1992). Pharmacology of r-hirudin in renal impairment. Thrombosis Research. 66(6). 707–715. 66 indexed citations
16.
Nowak, G & Elke Bucha. (1992). Ecarin-induced meizothrombin formation — An efficient antidote of hirudin. Thrombosis Research. 65. S157–S157. 1 indexed citations
17.
Hohlfeld, Thomas, et al.. (1992). Favourable effect of defibrotide in lipid A-induced shock in pigs.. PubMed. 38(2). 122–9. 5 indexed citations
18.
Markwárdt, F, G Nowak, & Elke Bucha. (1991). Hirudin as Anticoagulant in Experimental Hemodialysis. Pathophysiology of Haemostasis and Thrombosis. 21(Suppl. 1). 149–155. 13 indexed citations
19.
Bucha, Elke, F Markwárdt, & G Nowak. (1990). Hirudin in haemodialysis. Thrombosis Research. 60(6). 445–455. 20 indexed citations
20.
Bucha, Elke, G Nowak, & F Markwárdt. (1988). Prevention of experimental coronary thrombosis by hirudin.. PubMed. 115(1-2). 52–8. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026